Realcan Pharmaceutical Group Co., Ltd. (002589.SZ)
CNY 2.95
(4.24%)
CNY 2.95
(4.24%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 20.31 Million CNY | 101.17% |
| 2022 | -1.73 Billion CNY | -555.34% |
| 2021 | 382.01 Million CNY | -38.83% |
| 2020 | 624.55 Million CNY | 243.58% |
| 2019 | -434.97 Million CNY | -134.04% |
| 2018 | 1.27 Billion CNY | -6.62% |
| 2017 | 1.36 Billion CNY | 131.64% |
| 2016 | 590.75 Million CNY | 150.39% |
| 2015 | 235.93 Million CNY | 30.36% |
| 2014 | 180.98 Million CNY | 26.07% |
| 2013 | 143.55 Million CNY | 29.74% |
| 2012 | 110.65 Million CNY | 31.64% |
| 2011 | 84.05 Million CNY | 35.34% |
| 2010 | 62.1 Million CNY | 38.77% |
| 2009 | 44.75 Million CNY | 53.39% |
| 2008 | 29.17 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 7.78 Million CNY | -50.93% |
| 2024 Q1 | 15.16 Million CNY | 1282.05% |
| 2024 Q2 | 15.85 Million CNY | 4.53% |
| 2023 Q3 | -11.44 Million CNY | -220.4% |
| 2023 Q4 | 1.09 Million CNY | 109.59% |
| 2023 FY | 20.31 Million CNY | 101.17% |
| 2023 Q1 | 29.98 Million CNY | 101.59% |
| 2023 Q2 | 9.5 Million CNY | -68.29% |
| 2022 Q3 | 7.36 Million CNY | -81.33% |
| 2022 Q4 | -1.88 Billion CNY | -25706.08% |
| 2022 FY | -1.73 Billion CNY | -555.34% |
| 2022 Q1 | 98.57 Million CNY | 1429.1% |
| 2022 Q2 | 39.42 Million CNY | -60.01% |
| 2021 FY | 382.01 Million CNY | -38.83% |
| 2021 Q2 | 33.89 Million CNY | -58.49% |
| 2021 Q3 | 89.01 Million CNY | 162.59% |
| 2021 Q4 | -7.41 Million CNY | -108.33% |
| 2021 Q1 | 81.65 Million CNY | 272.21% |
| 2020 Q4 | -47.41 Million CNY | -148.18% |
| 2020 Q3 | 98.41 Million CNY | -14.19% |
| 2020 FY | 624.55 Million CNY | 243.58% |
| 2020 Q1 | 95.6 Million CNY | 106.35% |
| 2020 Q2 | 114.69 Million CNY | 19.97% |
| 2019 Q2 | 193.21 Million CNY | 1.76% |
| 2019 Q3 | 195.57 Million CNY | 1.22% |
| 2019 FY | -434.97 Million CNY | -134.04% |
| 2019 Q1 | 189.87 Million CNY | 446.97% |
| 2019 Q4 | -1.5 Billion CNY | -870.27% |
| 2018 Q3 | 253.01 Million CNY | -15.68% |
| 2018 FY | 1.27 Billion CNY | -6.62% |
| 2018 Q4 | -54.72 Million CNY | -121.63% |
| 2018 Q2 | 300.07 Million CNY | 7.06% |
| 2018 Q1 | 280.29 Million CNY | -1.97% |
| 2017 FY | 1.36 Billion CNY | 131.64% |
| 2017 Q3 | 208.16 Million CNY | -6.27% |
| 2017 Q4 | 285.92 Million CNY | 37.35% |
| 2017 Q2 | 222.08 Million CNY | -23.95% |
| 2017 Q1 | 292.03 Million CNY | 33.74% |
| 2016 FY | 590.75 Million CNY | 150.39% |
| 2016 Q2 | 131.74 Million CNY | 54.16% |
| 2016 Q3 | 155.18 Million CNY | 17.8% |
| 2016 Q4 | 218.36 Million CNY | 40.71% |
| 2016 Q1 | 85.46 Million CNY | 21.99% |
| 2015 Q2 | 52.29 Million CNY | 2.57% |
| 2015 Q3 | 62.6 Million CNY | 19.71% |
| 2015 Q4 | 70.05 Million CNY | 11.9% |
| 2015 FY | 235.93 Million CNY | 30.36% |
| 2015 Q1 | 50.98 Million CNY | -1.68% |
| 2014 Q3 | 50.18 Million CNY | 28.59% |
| 2014 Q2 | 39.02 Million CNY | -2.22% |
| 2014 Q1 | 39.91 Million CNY | -9.09% |
| 2014 FY | 180.98 Million CNY | 26.07% |
| 2014 Q4 | 51.85 Million CNY | 3.33% |
| 2013 Q2 | 30.35 Million CNY | -0.19% |
| 2013 FY | 143.55 Million CNY | 29.74% |
| 2013 Q4 | 43.9 Million CNY | 12.93% |
| 2013 Q3 | 38.87 Million CNY | 28.08% |
| 2013 Q1 | 30.41 Million CNY | -9.62% |
| 2012 Q4 | 33.64 Million CNY | 11.17% |
| 2012 Q3 | 30.26 Million CNY | 30.57% |
| 2012 Q2 | 23.18 Million CNY | -1.59% |
| 2012 Q1 | 23.55 Million CNY | -19.09% |
| 2012 FY | 110.65 Million CNY | 31.64% |
| 2011 FY | 84.05 Million CNY | 35.34% |
| 2011 Q3 | 21.62 Million CNY | 18.06% |
| 2011 Q2 | 18.31 Million CNY | 22.05% |
| 2011 Q1 | 15 Million CNY | -26.69% |
| 2011 Q4 | 29.11 Million CNY | 34.63% |
| 2010 Q2 | 14.34 Million CNY | 28.29% |
| 2010 Q4 | 20.47 Million CNY | 27.05% |
| 2010 FY | 62.1 Million CNY | 38.77% |
| 2010 Q1 | 11.18 Million CNY | 0.0% |
| 2010 Q3 | 16.11 Million CNY | 12.32% |
| 2009 FY | 44.75 Million CNY | 53.39% |
| 2008 FY | 29.17 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| China National Accord Medicines Corporation Ltd. | 1.59 Billion CNY | 98.73% |
| Shenzhen Glory Medical Co.,Ltd. | -148.88 Million CNY | 113.646% |